Article
Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma
19 Feb 2013
Abstract excerpt
Molecular targeted therapy is expected to be a promising therapeutic approach for the treatment of esophageal squamous cell carcinoma (ESCC); however, the gene amplification status of molecular targeted genes in ESCC remains largely unclear. The gene amplification of EGFR, HER2, FGFR2 and MET was examined using a real-time PCR-based copy number assay of 245 ESCC surgical specimens of formalin-fixed,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
